New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Assessing the effects of the COVID-19 pandemic on cancer prevention

Assessing the effects of the COVID-19 pandemic on cancer prevention

byQueen Mary, University of LondonCredit: CC0 Public DomainA review of the international effects of the COVID-19 pandemic on cancer prevention, led by researchers at Queen Mary University of Lon
World medicine December 13,2023
Assessing the effects of the COVID-19 pandemic on cancer prevention

Assessing the effects of the COVID-19 pandemic on cancer prevention

byQueen Mary, University of LondonCredit: CC0 Public DomainA review of the international effects of the COVID-19 pandemic on cancer prevention, led by researchers at Queen Mary University of Lon
World medicine December 13,2023
Subcutaneous securement system best for reaching end of PICC need

Subcutaneous securement system best for reaching end of PICC need

by Elana GotkineA subcutaneous anchor securement system (SASS) is superior for assisting oncology patients to reach the end of need with a single peripherally inserted central catheter (PICC), accordi
World medicine December 13,2023
Subcutaneous securement system best for reaching end of PICC need

Subcutaneous securement system best for reaching end of PICC need

by Elana GotkineA subcutaneous anchor securement system (SASS) is superior for assisting oncology patients to reach the end of need with a single peripherally inserted central catheter (PICC), accordi
World medicine December 13,2023
Electrical signals between skin cells may influence melanoma initiation

Electrical signals between skin cells may influence melanoma initiation

byAmerican Association for Cancer ResearchHuman skin structure. Credit: WikipediaThe transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered e
World medicine December 13,2023
Electrical signals between skin cells may influence melanoma initiation

Electrical signals between skin cells may influence melanoma initiation

byAmerican Association for Cancer ResearchHuman skin structure. Credit: WikipediaThe transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered e
World medicine December 13,2023
Discovery could lead to new treatment for rare blood disease

Discovery could lead to new treatment for rare blood disease

by Adrianna MacPherson,University of Alberta Faculty of Medicine & DentistryU of A dermatologist Robert Gniadecki discovered that cancer cells found in skin lesions on patients with T cell l
World medicine December 13,2023
Discovery could lead to new treatment for rare blood disease

Discovery could lead to new treatment for rare blood disease

by Adrianna MacPherson,University of Alberta Faculty of Medicine & DentistryU of A dermatologist Robert Gniadecki discovered that cancer cells found in skin lesions on patients with T cell l
World medicine December 13,2023
Initiative helps increase breast cancer screening

Initiative helps increase breast cancer screening

bySwinburne University of TechnologyCredit: CC0 Public DomainA new study has found that using a community-codesign approach can massively increase mammography screening rates among Italian and A
World medicine December 13,2023
Initiative helps increase breast cancer screening

Initiative helps increase breast cancer screening

bySwinburne University of TechnologyCredit: CC0 Public DomainA new study has found that using a community-codesign approach can massively increase mammography screening rates among Italian and A
World medicine December 13,2023
Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

byKarolinska InstitutetThe researchers found NK cells in skin from patients with cutaneous lymphoma. Here immunofluorescence identifying CD56+CD3-NK cells (green cells, marked with yellow
World medicine December 13,2023
Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

Impaired natural killer cells in cutaneous lymphoma: Possible new targets for future therapies

byKarolinska InstitutetThe researchers found NK cells in skin from patients with cutaneous lymphoma. Here immunofluorescence identifying CD56+CD3-NK cells (green cells, marked with yellow
World medicine December 13,2023
Young cancer survivors at higher risk for hospitalization

Young cancer survivors at higher risk for hospitalization

(HealthDay)—Adolescent and young adult (AYA) cancer survivors (aged 15 to 39 years) have an increased risk for inpatient hospitalization, according to a study published online Jan. 20 inCancer E
World medicine December 13,2023
Young cancer survivors at higher risk for hospitalization

Young cancer survivors at higher risk for hospitalization

(HealthDay)—Adolescent and young adult (AYA) cancer survivors (aged 15 to 39 years) have an increased risk for inpatient hospitalization, according to a study published online Jan. 20 inCancer E
World medicine December 13,2023
New CAR-T target yields promising results for multiple myeloma

New CAR-T target yields promising results for multiple myeloma

by Huntsman Cancer InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Too many patients with cancers like multiple myelom
World medicine December 13,2023
New CAR-T target yields promising results for multiple myeloma

New CAR-T target yields promising results for multiple myeloma

by Huntsman Cancer InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Too many patients with cancers like multiple myelom
World medicine December 13,2023
Study provides new understanding of mitochondria genome, potential for new avenues of treatment for cancers

Study provides new understanding of mitochondria genome, potential for new avenues of treatment for cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainA study led by The University of Texas MD Anderson Cancer Center furthered understanding about mitochondria, the cell c
World medicine December 13,2023
Study provides new understanding of mitochondria genome, potential for new avenues of treatment for cancers

Study provides new understanding of mitochondria genome, potential for new avenues of treatment for cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainA study led by The University of Texas MD Anderson Cancer Center furthered understanding about mitochondria, the cell c
World medicine December 13,2023
Stem cells, CRISPR and gene sequencing technology are basis of new brain cancer model

Stem cells, CRISPR and gene sequencing technology are basis of new brain cancer model

byUniversity of California - San DiegoCredit: CC0 Public DomainUsing genetically engineered human pluripotent stem cells, University of California San Diego School of Medicine researchers create
World medicine December 13,2023
Stem cells, CRISPR and gene sequencing technology are basis of new brain cancer model

Stem cells, CRISPR and gene sequencing technology are basis of new brain cancer model

byUniversity of California - San DiegoCredit: CC0 Public DomainUsing genetically engineered human pluripotent stem cells, University of California San Diego School of Medicine researchers create
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com